Published in Curr Opin Hematol on May 01, 2010
Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev (2011) 2.06
RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development. J Exp Med (2014) 1.42
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration. J Exp Med (2013) 1.10
Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles. PLoS One (2012) 0.93
Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins. J Exp Med (2013) 0.92
Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation. PLoS One (2012) 0.91
Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2. Blood (2012) 0.83
Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production. Hematol Oncol Clin North Am (2014) 0.80
Erythropoiesis stimulating agents: approaches to modulate activity. Biologics (2013) 0.80
Differential proteomic analysis of human erythroblasts undergoing apoptosis induced by epo-withdrawal. PLoS One (2012) 0.80
The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection. Med Sci Monit (2013) 0.79
In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain. PLoS One (2015) 0.76
Establishment of a cell-type-specific genetic network by the mediator complex component Med1. Mol Cell Biol (2013) 0.75
Novel Roles for Podocalyxin in Regulating Stress Myelopoiesis, Rap1a and Neutrophil Migration. Exp Hematol (2017) 0.75
Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Cell Rep (2017) 0.75
Epo reprograms the epigenome of erythroid cells. Exp Hematol (2017) 0.75
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell (2001) 19.75
A conserved family of prolyl-4-hydroxylases that modify HIF. Science (2001) 11.50
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet (2003) 11.47
Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A (1990) 7.39
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med (2002) 7.00
JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell (1993) 6.04
Jak2 is essential for signaling through a variety of cytokine receptors. Cell (1998) 5.92
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med (1987) 5.57
Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science (1996) 5.19
Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell (1995) 4.73
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell (1999) 4.69
Expression cloning of the murine erythropoietin receptor. Cell (1989) 4.59
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature (2001) 4.35
Role of the kidney in erythropoiesis. Nature (1957) 3.75
Transcriptional control of granulocyte and monocyte development. Oncogene (2007) 3.49
Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science (1990) 3.46
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A (2004) 3.40
A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia. N Engl J Med (2009) 3.37
Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A (1985) 3.28
TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science (2006) 3.26
New avenues of exploration for erythropoietin. JAMA (2005) 3.23
Hematopoietic cytokines can instruct lineage choice. Science (2009) 3.01
Purification of human erythropoietin. J Biol Chem (1977) 2.83
Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol (2005) 2.82
The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol (1991) 2.77
SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol (2008) 2.72
VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med (2006) 2.67
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med (2008) 2.55
Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol (2003) 2.53
Signalling hypoxia by HIF hydroxylases. Biochem Biophys Res Commun (2005) 2.50
HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest (2009) 2.47
Hematopoietic cytokines. Blood (2008) 2.45
Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest (2008) 2.45
Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest (2007) 2.39
Novel functions of the CD34 family. J Cell Sci (2008) 2.18
Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood (2005) 2.17
The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell (2001) 2.10
Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development (2000) 2.10
A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood (2009) 2.08
Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene (2002) 1.93
HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood (2007) 1.87
Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. Mol Cell (2003) 1.84
Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med (2007) 1.83
Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell (2009) 1.82
The non-haematopoietic biological effects of erythropoietin. Br J Haematol (2008) 1.81
STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene (2006) 1.79
The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction. Trends Endocrinol Metab (1999) 1.79
Weighing the hazards of erythropoiesis stimulation in patients with cancer. N Engl J Med (2007) 1.73
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A (2008) 1.70
Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J Clin Invest (2006) 1.69
MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell (2009) 1.66
Humoral regulation of red cell production. Blood (1953) 1.60
Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A (1997) 1.57
New agents that stimulate erythropoiesis. Blood (2006) 1.53
Survival and invasiveness of astrocytomas promoted by erythropoietin. J Neurosurg (2007) 1.51
The many faces of the SOCS box. Cytokine Growth Factor Rev (2008) 1.50
Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood (2005) 1.41
Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev (2006) 1.40
The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. J Clin Invest (2009) 1.40
LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev Cell (2009) 1.39
Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J Biol Chem (2006) 1.37
SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol Cell Biol (2005) 1.36
The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. J Mol Biol (2009) 1.35
Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Mol Cell Biol (2007) 1.34
EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts. Blood (2007) 1.33
Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat Immunol (2004) 1.31
Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal (2005) 1.30
Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia (2007) 1.29
The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood (2007) 1.27
EPO receptor circuits for primary erythroblast survival. Blood (2008) 1.26
Erythropoietin and erythropoiesis. Exp Hematol (2009) 1.26
Core erythropoietin receptor signals for late erythroblast development. Blood (2005) 1.26
beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood (2007) 1.25
Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood (1950) 1.24
Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Mol Endocrinol (2003) 1.23
Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1991) 1.23
Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia (2005) 1.20
ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs. Proc Natl Acad Sci U S A (2008) 1.20
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci U S A (2008) 1.17
The Drosophila SH2B family adaptor Lnk acts in parallel to chico in the insulin signaling pathway. PLoS Genet (2009) 1.17
Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood (1999) 1.14
Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J (2007) 1.14
Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin. Blood (2005) 1.13
STAT5 signaling in normal and pathologic hematopoiesis. Front Biosci (2007) 1.11
Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry (1998) 1.10
Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Kidney Int (2007) 1.10
NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ Res (2009) 1.10
Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood (1993) 1.10
Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J Leukoc Biol (2009) 1.10
Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia. Exp Hematol (2006) 1.08
Erythropoietin and renoprotection. Curr Opin Nephrol Hypertens (2009) 1.07
Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia. Blood (2009) 1.07
Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. Blood (2007) 1.06
Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell Signal (2008) 1.04
Cytokine receptors and hematopoietic differentiation. Oncogene (2007) 1.04
CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools. Blood (2009) 1.01
A potent erythropoietin-mimicking human antibody interacts through a novel binding site. Blood (2007) 1.01
Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives. Clin Cancer Res (2008) 1.01
In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev Cell (2006) 2.30
Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J Biol Chem (2003) 1.49
Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J Biol Chem (2002) 1.43
EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts. Blood (2007) 1.33
EPO receptor circuits for primary erythroblast survival. Blood (2008) 1.26
Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells. Oncogene (2004) 1.23
miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia. Am J Hematol (2012) 1.06
Putative human male germ cells from bone marrow stem cells. Soc Reprod Fertil Suppl (2007) 1.04
During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool. Blood (2010) 0.98
A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis. Exp Hematol (2008) 0.94
Erythropoietin-dependent erythropoiesis: New insights and questions. Blood Cells Mol Dis (2006) 0.93
Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation. PLoS One (2012) 0.91
miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia. Leuk Res (2011) 0.90
Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4. Hum Mol Genet (2007) 0.90
Premature translation of transition protein 2 mRNA causes sperm abnormalities and male infertility. Mol Reprod Dev (2007) 0.88
TRAF2-MLK3 interaction is essential for TNF-alpha-induced MLK3 activation. Cell Res (2009) 0.86
Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2. Blood (2012) 0.83
DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia. J Biol Chem (2008) 0.82
Cryptic collagen IV promotes cell migration and adhesion in myeloid leukemia. Cancer Med (2014) 0.79
A newborn with hereditary haemorrhagic telangiectasia and an unusually severe phenotype. Swiss Med Wkly (2008) 0.78